Format

Send to

Choose Destination
J Biotechnol. 2002 Jan;82(3):279-300.

Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products.

Author information

1
Q-One Biotech Ltd., West of Scotland Science Park, Glasgow, Scotland, UK. alovatt@q-one.co.uk

Abstract

High throughput screening, increased accuracy and the coupling of real-time quantitative PCR (Q-PCR) to robotic set-up systems are beginning to revolutionise biotechnology. Applications of Q-PCR within biotechnology are discussed with particular emphasis on the following areas of biosafety and genetic stability testing: (a) determination of the biodistribution of gene therapy vectors in animals; (b) quantification of the residual DNA in final product therapeutics; (c) detection of viral and bacterial nucleic acid in contaminated cell banks and final products; (d) quantification of the level of virus removal in process validation viral clearance studies; (e) specific detection of retroviral RT activity in vaccines with high sensitivity; and (f) transgene copy number determination for monitoring genetic stability during production. Methods employed for Q-PCR assay validation as required in ICH Topic Q2A Validation of Analytical Methods: Definitions and Terminology (1st June 1995) are also reviewed.

PMID:
11999695
DOI:
10.1016/s1389-0352(01)00043-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center